Charles N. York II, COO, CFO AND SECRETARY at Day One Biopharmaceuticals, Inc. (DAWN), sold 120,722 shares at $17.85 ($2.2M) on 2024-05-03, disclosed to the SEC on 2024-05-03.
Scheduled sale ($2.2M) by COO, CFO AND SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.89 | 52,183 | $934K | 43.2% |
| 2 | $17.89 | 52,183 | $934K | 43.2% |
| 3 | $17.90 | 200 | $4K | 0.2% |
| 4 | $17.85 | 8,078 | $144K | 6.7% |
| 5 | $17.85 | 8,078 | $144K | 6.7% |
| Total | $17.88 avg | 120,722 |
| $2.2M |
| 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $28K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $27K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $105K | — | Filing → |